Effects of COVID-19 Lockdown on Tumour Burden of Melanoma and Cutaneous Squamous Cell Carcinoma
DOI:
https://doi.org/10.2340/00015555-3890Keywords:
melanoma, cutaneous squamous cell carcinoma, delay, surgery, COVID-19, SARS-CoV-2Abstract
The aim of this study was to compare tumour burden in patients who underwent surgery for melanoma and cutaneous squamous cell carcinoma during nationwide lockdown in Spain due to COVID-19 (for the period 14 March to 13 June 2020) and during the same dates in 2019 before the COVID-19 pandemic. In addition, associations between median tumour burden (Breslow thickness for melanoma and maximum clinical diameter for cutaneous squamous cell carcinoma) and demographic, clinical, and medical factors were analysed, building a multivariate linear regression model. During the 3 months of lockdown, there was a significant decrease in skin tumours operated on (41% decrease for melanoma (n = 352 vs n = 207) and 44% decrease for cutaneous squamous cell carcinoma (n = 770 vs n = 429)) compared with the previous year. The proportion of large skin tumours operated on increased. Fear of SARS-CoV-2 infection, with respect to family member/close contact, and detection of the lesion by the patient or doctor, were related to thicker melanomas; and fear of being diagnosed with cancer, and detection of the lesion by the patient or relatives, were related to larger size cutaneous squamous cell carcinoma. In conclusion, lockdown due to COVID-19 has resulted in a reduction in treatment of skin cancer.
Downloads
References
Tejera-Vaquerizo A, Nagore E. Estimated effect of COVID-19 lockdown on melanoma thickness and prognosis: a rate of growth model. J Eur Acad Dermatol Venereol 2020; 34: e351–e353.
Tejera-Vaquerizo A, Cañueto J, Toll A, Santos-Juanes J, Jaka A, Ferrandiz-Pulido C, et al. Estimated effect of COVID-19 lockdown on skin tumor size and survival: an exponential growth model. Actas Dermo-Sifiliograficas 2020; 111: 629–638.
NCCN. Short-term Recommendations for Cutaneous Melanoma Management during COVID-19 Pandemic. Coronavirus Disease 2019 (COVID-19) Resources for the Cancer Care Community [accessed 7 Dec 2020]. Available from: https://www.nccn.org/covid-19/pdf/Melanoma.pdf.
Russo F. Current evidence of one-step surgical treatment in cutaneous melanoma. Actas Dermosifiliogr 2020; 111: 541–544.
Tejera-Vaquerizo A, Russo F, Nieto-González G. Skin lesion suspicious of melanoma: time to one-step removal. J Prim Health Care 2019; 11: 87.
British Association of Dermatologists & British Society for Dermatological Surgery COVID-19-Skin cancer surgery guidance. Clinical guidance for the management of skin cancer patients during the coronavirus pandemic [accessed 7 Dec 2020]. Available from: http://www.bad.org.uk/healthcare.
American College of Mohs Surgery: COVID-19 (Coronavirus) preparedness. COVID-19 (Coronavirus) Preparedness [accessed 7 Dec 2020]. Available from: https://www.mohscollege.org/UserFiles/AM20/Member Alert/COVIDAlert3March20.pdf.
Ricci F, Fania L, Paradisi A, Di Lella G, Pallotta S, Sobrino L, et al. Delayed melanoma diagnosis in the COVID-19 era: increased breslow thickness in primary melanomas seen after the COVID-19 lockdown. J Eur Acad Dermatol Venereol 2020; 34: e778–e779.
Barruscotti S, Giorgini C, Brazzelli V, Vassallo C, Michelerio A, Klersy C, et al. A significant reduction in the diagnosis of melanoma during the COVID-19 lockdown in a third-level center in the Northern Italy. Dermatol Ther 2020; 33: e14074.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507–513.
Gomolin T, Cline A, Handler MZ. The danger of neglecting melanoma during the COVID-19 pandemic. J Dermatolog Treat 2020; 31: 444–445.
Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The fear of COVID-19 scale: development and initial validation. Int J Ment Health Addict 2020 Mar 27. [Epub ahead of print].
Vrinten C, McGregor LM, Heinrich M, von Wagner C, Waller J, Wardle J, et al. What do people fear about cancer? A systematic review and meta-synthesis of cancer fears in the general population. Psycho-Oncology 2017; 26: 1070–1079.
Block LM, Jee YM, Baskaya MK, Bentz ML, Poore SO. Denying the obvious: four extreme cases of neglected tumors. Plast Reconstr Surg Glob Open 2015; 3: e571.
Avilés-Izquierdo JA, Molina-López I, Rodríguez-Lomba E, Marquez-Rodas I, Suarez-Fernandez R, Lazaro-Ochaita P. Who detects melanoma? Impact of detection patterns on characteristics and prognosis of patients with melanoma. J Am Acad Dermatol 2016; 75: 967–974.
Additional Files
Published
How to Cite
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
